Latest News for: kinases
Edit
Fremont Tribune
20 Mar 2025
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association ...
Fremont Tribune
20 Mar 2025
Clinical data highlight survival benefits and improvement in ...
Edit
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
Pharmiweb 19 Mar 2025
Thymidine kinase 2 deficiency is an ultra-rare, life-threatening, genetic mitochondrial disease characterized by progressive and severe muscle weakness (myopathy), which can impact the ability to walk, eat, and breathe independently.6,7,8,9,10.
Edit
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference (UCB SA)
Public Technologies 19 Mar 2025
) New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference ... About thymidine kinase 2 deficiency (TK2d) ... Patients' Lived Experience of Thymidine Kinase 2 Deficiency (TK2d).
Edit
Staphylococcus aureus uses a GGDEF protein to recruit diacylglycerol kinase to the membrane for lipid recycling
PNAS 18 Mar 2025
In Gram-positive bacteria, a soluble diacylglycerol (DAG) kinase ...
Edit
Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping in Phase 1/2 EXPLORE44® Trial
PR Newswire 17 Mar 2025
"Del-zota has shown remarkable improvements across multiple measures, including a substantial increase in dystrophin production and a significant reduction in serum creatine kinase levels to near normal after just three doses.
- 1